A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sara Gianella, MD
University of California, San Diego, AntiViral Research Center CRS
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsd Antiviral Research Center Crs (site 701)
San Diego, California, United States
- Ucsf Hiv/aids Crs (site 801)
San Francisco, California, United States
- University of Colorado Hospital Crs
Aurora, Colorado, United States
- Northwestern University Crs
Chicago, Illinois, United States
- Massachusetts General Hospital Crs (mgh Crs)
Boston, Massachusetts, United States
- Washington University Therapeutics (wt) Crs
St Louis, Missouri, United States
- Weill Cornell Chelsea Crs (7804)
New York, New York, United States
- Weill Cornell Uptown Crs (7803)
New York, New York, United States
- University of Rochester Adult Hiv Therapeutic Strategies Network Crs
Rochester, New York, United States
- Cincinnati Clinical Research Site
Cincinnati, Ohio, United States
- Case Clinical Research Site
Cleveland, Ohio, United States
- Penn Therapeutics, Crs
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Crs
Pittsburgh, Pennsylvania, United States
- Vanderbilt Therapeutics (vt) Crs
Nashville, Tennessee, United States
- University of Washington Positive Research Crs
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Apr 2022
- Primary completion
- 30 Nov 2023
- Completion
- 30 Nov 2023
- Last update posted
- 4 Mar 2025
- Registered enrollment
- 44
- Registry id
- NCT04840199
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.